Quick answer
This page lists 80 immunotherapy doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Immunotherapy doctors in India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Immunotherapy doctors
FeaturedDr. Vinod Raina
MBBS, MD (Internal Medicine), DM (Medical Oncology), Fellowship, Fellowship
Chairman – Medical Oncology · Specialty: Medical Oncologist
Fortis Memorial Research Institute Gurgaon, India40+ Years experience
Why consider this doctor?
- 40+ years of experience in Medical Oncologist
- Chairman – Medical Oncology, Fortis Memorial Research Institute, Gurugram (Present)
- Professor and Head of Medical Oncology, AIIMS, New Delhi (2001 – 2013)
Expertise & Procedures
- High-Dose Chemotherapy with Stem Cell Rescue
- Autologous Bone Marrow Transplant
- Chemotherapy (Induction, Consolidation, Maintenance)
- Concurrent Chemoradiotherapy
- Palliative Chemotherapy
Medical Oncologist Experience: 40+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Pooja Babbar
MBBS, MD Radiation Oncology, Senior Residency, DM Medical Oncology – Gold Medalist, European Certification in Medical Oncology (ESMO), Diploma in Medico Legal System, MBA in Hospital Management
Consultant & Unit Head – Medical Oncology · Specialty: Medical Oncologist
Fortis Hospital Manesar Gurugram, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist
- Consultant & Unit Head – Medical Oncology, Fortis Hospital, Manesar, Gurugram (Present)
- American Oncology Institute, Gurugram
Expertise & Procedures
- Chemotherapy (Adjuvant, Neoadjuvant, Palliative)
- Immunotherapy (Checkpoint Inhibitors)
- Targeted Therapy (HER2, EGFR, VEGF, CDK4/6 inhibitors)
- Hormonal Therapy (Breast, Prostate cancer)
- Oncological Emergency Management
Medical Oncologist Experience: 11+ YearsHospital Affiliation: Fortis Hospital ManesarHospital accreditation: NABH, NABL, JCI
Dr. Ashok Kumar Vaid
MBBS, MD (General Medicine), DM (Medical Oncology)
Chairman — Medical Oncology, Hematology & Stem Cell Transplant · Specialty: Medical Oncologist & BMT Specialist
Medanta - The Medicity Gurgaon, India44+ Years experience
Why consider this doctor?
- 44+ years of experience in Medical Oncologist & BMT Specialist
- Chairman — Medical Oncology, Hematology & Stem Cell Transplant, Medanta – The Medicity, Gurgaon (Present)
- Pioneered one of the largest stem cell transplant programmes in private-sector north India
Expertise & Procedures
- Allogeneic Stem Cell Transplant
- Autologous Stem Cell Transplant
- Haploidentical Stem Cell Transplant
- Bone Marrow Aspiration & Biopsy
- Chemotherapy Administration
Medical Oncologist & BMT Specialist Experience: 44+ YearsHospital Affiliation: Medanta - The MedicityHospital accreditation: JCI, NABH
Dr. Imran Khan
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP — Medical Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Escorts Heart Institute New Delhi, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Fortis Escorts, Okhla Road, New Delhi (Present)
- Associate Consultant — Medical Oncology, Fortis Escorts, Amritsar
Expertise & Procedures
- Chemotherapy Administration
- Targeted Therapy Infusions
- Immunotherapy Infusions
- PICC Line Insertion
- Bone Marrow Aspiration & Biopsy
Medical Oncologist Experience: 10+ YearsHospital Affiliation: Fortis Escorts Heart InstituteHospital accreditation: JCI, NABH
Dr. Huma Noor
MBBS, MD (General Medicine), DM (Medical Oncology), MRCP — Medical Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Escorts Heart Institute New Delhi, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Fortis Escorts, Okhla Road, New Delhi (Present)
- Consultant — Medical Oncology, Fortis Escorts, Amritsar
Expertise & Procedures
- Chemotherapy Administration
- Immunotherapy Infusions
- Targeted & Hormonal Therapy
- Autologous Stem Cell Transplant
- Allogeneic Stem Cell Transplant (Paediatric & Adult)
Medical Oncologist Experience: 11+ YearsHospital Affiliation: Fortis Escorts Heart InstituteHospital accreditation: JCI, NABH
(Lt Gen) Dr. C. S. Narayanan, VSM
MBBS, MD (Medicine), DM (Neurology)
Chairman — Manipal Institute of Neuro Sciences · Specialty: Neurologist
Manipal Hospital Dwarka New Delhi, India35+ Years experience
Why consider this doctor?
- 35+ years of experience in Neurologist
- Chairman, Manipal Institute of Neuro Sciences, Manipal Hospital Dwarka, New Delhi — Present
- Consultant Neurologist, Manipal Hospital Dwarka, New Delhi — Present
Expertise & Procedures
- Video EEG Monitoring and Analysis
- Intravenous Thrombolysis (tPA) for Acute Stroke
- Mechanical Thrombectomy for Large Vessel Occlusion
- Nerve Conduction Velocity (NCV) and EMG Studies
- Comprehensive Movement Disorder Assessment and Management
Neurologist Experience: 35+ YearsHospital Affiliation: Manipal Hospital DwarkaHospital accreditation: NABH, NABL
Dr. Dipanjan Panda
MBBS, MD (General Medicine), DM (Medical Oncology)
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Indraprastha Apollo Hospitals New Delhi, India15+ Years experience
Why consider this doctor?
- 15+ years of experience in Medical Oncologist
- Senior Consultant — Medical Oncology, Indraprastha Apollo Hospitals, New Delhi (Present)
- Associate Professor & HOD — Medical Oncology, Institute of Liver and Biliary Sciences (ILBS), New Delhi
Expertise & Procedures
- Systemic chemotherapy for solid tumours
- Targeted therapy regimens
- Immunotherapy (checkpoint inhibitors)
- Oral chemotherapy management
- Adjuvant and neo-adjuvant cancer treatment planning
Medical Oncologist Experience: 15+ YearsHospital Affiliation: Indraprastha Apollo Hospitals
Dr. Sai Lakshmi Daayana
MBBS, MS, MRCOG
Consultant — Obstetrics, Gynecology & Gynecologic Oncology · Specialty: Gynecologic Oncosurgeon
Apollo Hospital Jubilee Hills Hyderabad, India22+ Years experience
Why consider this doctor?
- 22+ years of experience in Gynecologic Oncosurgeon
- Consultant — Obstetrics, Gynecology & Gynecologic Oncology, Apollo Hospital Jubilee Hills, Hyderabad, India
- Clinical Lecturer in Surgical Gynaecological Oncology, Christie Hospital, Manchester, United Kingdom
Expertise & Procedures
- Radical hysterectomy with pelvic lymphadenectomy
- Sentinel lymph node biopsy in gynecologic cancer
- Cytoreductive surgery for advanced ovarian cancer
- Cervical cancer surgical management and reconstruction
- Vulvar cancer wide local excision and inguinal lymphadenectomy
Gynecologic Oncosurgeon Experience: 22+ YearsHospital Affiliation: Apollo Hospital Jubilee HillsHospital accreditation: JCI, NABH
Dr. M. Janarthinakani
MBBS, MD
Senior Consultant — Radiation Oncology · Specialty: Radiation Oncologist
Rela Hospital Chennai, India25+ Years experience
Why consider this doctor?
- 25+ years of experience in Radiation Oncologist
- Senior Consultant, Radiation Oncology — Rela Hospital, Chennai
- Consultant and Educator — Cancer Institute (WIA), Adyar, Chennai
Expertise & Procedures
- Image-Guided Radiation Therapy (IMRT)
- Stereotactic Body Radiation Therapy (SBRT)
- Brachytherapy for Cervical and Rectal Cancers
- 3D Conformal Radiation Therapy
- Intensity-Modulated Radiation Therapy Planning
Radiation Oncologist Experience: 25+ YearsHospital Affiliation: Rela HospitalHospital accreditation: NABH, NABL
Dr. Sapna Manocha Verma
MBBS, MD in Radiotherapy
Senior Consultant — Radiation Oncology · Specialty: Radiation Oncologist
Indraprastha Apollo Hospital Delhi NCR, India22+ Years experience
Why consider this doctor?
- 22+ years of experience in Radiation Oncologist
- Senior Consultant — Radiation Oncology, Indraprastha Apollo Hospital, Delhi NCR, Present
- Extensive clinical practice across major cancer centers in India with 22+ years of dedicated experience in radiation oncology and multimodal cancer management
Expertise & Procedures
- Stereotactic Body Radiation Therapy (SBRT)
- Stereotactic Radiosurgery
- Brachytherapy
- 3D Conformal Radiation Therapy
- Intensity-Modulated Radiation Therapy (IMRT)
Radiation Oncologist Experience: 22+ YearsHospital Affiliation: Indraprastha Apollo HospitalHospital accreditation: JCI, NABH
Hospitals where these doctors practise
🇮🇳 Manesar, Gurgaon, IndiaStarting from$1,000
Fortis Hospital Manesar
Est. 2013
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditationJCI — Joint Commission International accreditation
ImmunotherapyCardiac SurgeryOrthopedicsBariatric Surgery
1+
Doctors for Immunotherapy
4.4
74 reviews
350+
Beds
13+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$1,000
Medanta - The Medicity
Est. 2009
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyCardiac SurgeryCardiologyMedical Oncology
10+
Doctors for Immunotherapy
4.9
2150 reviews
1600+
Beds
17+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
Fortis Escorts Heart Institute
Est. 1988
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyCardiac SurgeryCardiologyMedical Oncology
2+
Doctors for Immunotherapy
4.5
24 reviews
310+
Beds
38+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
Manipal Hospitals Dwarka
Est. 2017
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
ImmunotherapyCardiologyOncologyOrthopedics
1+
Doctors for Immunotherapy
4.4
54 reviews
380+
Beds
9+
Years Since Founded
🇮🇳 Hyderabad, IndiaStarting from$1,000
Apollo Hospitals, Jubilee Hills
Est. 1988
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyCardiac SurgeryCardiologyMedical Oncology
5+
Doctors for Immunotherapy
4.1
44 reviews
550+
Beds
38+
Years Since Founded
🇮🇳 Chennai, IndiaStarting from$1,000
Dr. Rela Institute and Medical Centre
Est. 2018
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
ImmunotherapyCardiac SurgeryCardiologyMedical Oncology
4+
Doctors for Immunotherapy
4.7
108 reviews
450+
Beds
8+
Years Since Founded
🇮🇳 Chennai, IndiaStarting from$1,000
Apollo Hospitals, Greams Road
Est. 1983
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyCardiac SurgeryCardiologyMedical Oncology
5+
Doctors for Immunotherapy
4.7
125 reviews
560+
Beds
43+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
BLK-Max Super Speciality Hospital
Est. 1959
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyCardiac SurgeryCardiologyMedical Oncology
4+
Doctors for Immunotherapy
3.8
48 reviews
650+
Beds
67+
Years Since Founded
Why consider treatment in India?
Many international patients consider India for lung cancer treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
About the Procedure
What is Immunotherapy?
Immunotherapy uses drugs that help the patient's own immune system recognize and destroy cancer cells, and is used across many cancers including breast, lung, colorectal, gastric/esophageal, liver/pancreatic, ovarian/gynaecological, head & neck cancers, leukemia, lymphoma, and multiple myeloma. It is given as an infusion in cycles, either alone or combined with chemotherapy/targeted therapy, and India offers globally approved immunotherapy drugs and advanced options like CAR-T cell therapy at a fraction of Western costs. Treatment plans are individualized based on tumor type, biomarker status (e.g., PD-L1, MSI), and stage of disease.
Who may be considered?
Immunotherapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Drugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.
3 approaches available for this procedure:
Immune Checkpoint Inhibitor Therapy
Most CommonDrugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.
Comprehensive Investigations
Estimated cost: $400 - $1,500
CBC, liver and kidney function tests, thyroid function tests, PD-L1/MSI/biomarker testing, contrast CT/PET-CT, ECG, tumor board review
Treatment / Procedure Estimate
Estimated cost in India: $1,500 - $3,500 per cycle
Stay in India
Pre-procedure stay (outside hospital): ~2-3 days
Hospitalisation: ~1 day (day-care per cycle)
Recovery period (outside hospital): ~2-3 days recommended between cycles
Total stay: approx 4-6 cycles over 3-6 months
Usually Included in Hospital Package
- Oncologist consultations
- Day-care infusion facility
- Drug administration and monitoring
- Pre-cycle blood work
- Nursing care during infusion
Usually Not Included
- Cost of immunotherapy drug (billed per cycle)
- Interim PET-CT/imaging for response assessment
- Management of immune-related side effects if hospitalization needed
- Genetic/biomarker testing not covered under package
Recovery and follow-up
Most patients tolerate immunotherapy infusions as outpatients and can resume light activity within a day or two, though fatigue, skin rash, or flu-like symptoms are common and are monitored through regular blood tests before each cycle. CAR-T patients require a longer inpatient recovery period with close monitoring for delayed immune reactions.
Risks
Immunotherapy can trigger immune-related side effects affecting the skin, gut, lungs, liver, or endocrine glands, and rarely severe reactions like cytokine release syndrome (especially with CAR-T) that require prompt hospital management. Response to treatment varies by tumor type and biomarker status, and not all patients achieve remission.
Alternatives
Depending on the cancer type and stage, alternatives include conventional chemotherapy, targeted therapy, radiation therapy, hormonal therapy, surgery, or a combination approach as advised by the tumor board.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Histopathology and biopsy report confirming cancer type
- Biomarker/genetic testing results (PD-L1, HER2, MSI, EGFR, etc.)
- Recent CT/PET-CT/MRI imaging reports
- Complete blood count and liver/kidney function tests
- Previous chemotherapy/radiotherapy/surgery records
- Bone marrow biopsy report (for blood cancers)
- Cardiac evaluation report (ECG/ECHO)
- Discharge summaries from previous hospitalizations
Patient information needed
- Current age, weight, and general performance status
- Detailed cancer diagnosis with stage and biomarker status
- History of prior treatments and response to them
- Any known drug allergies or autoimmune conditions
- Current medications including steroids or immunosuppressants
- Presence of other chronic conditions (diabetes, heart or lung disease)
- Availability of a caregiver/attendant during treatment
- Preferred treatment start date and travel flexibility
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Immunotherapy) and procedure (Immunotherapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Immunotherapy in India
What is Lung Cancer?
Lung cancer is a malignant condition in which cells in one or both lungs multiply abnormally, most commonly arising in the cells lining the airways (non-small cell lung cancer) or in neuroendocrine cells of the lung (small cell lung cancer). The distinction between these types, along with the tumour's stage and molecular profile, directly shapes the treatment approach.
What are the symptoms and health risks of Lung Cancer?
Common symptoms include a persistent or worsening cough, coughing up blood, unexplained shortness of breath, chest pain, hoarseness, unintentional weight loss, and recurrent chest infections. As the disease progresses or spreads, symptoms such as bone pain, headache, or swelling in the face and neck may also appear. It is important to note that these symptoms overlap with many other conditions, and their presence alone is not sufficient to establish a diagnosis.
How is Lung Cancer diagnosed?
Diagnosis typically begins with a detailed clinical history and physical examination, followed by chest X-ray or CT scan to identify suspicious lesions. A tissue biopsy — obtained bronchoscopically, via CT-guided needle, or surgically — is required to confirm the cancer type and, increasingly, to test for specific genetic mutations (such as EGFR, ALK, or PD-L1 expression) that guide targeted therapy decisions. Staging, usually described using the TNM system (Stage I through IV for non-small cell, and limited versus extensive for small cell), along with PET scan and sometimes brain MRI, determines how far the cancer has spread and which treatment pathways are appropriate.
How is Lung Cancer treated?
Treatment depends heavily on the cancer type, stage, molecular markers, and the patient's overall lung function and health status. Early-stage non-small cell lung cancer may be treated with surgery, stereotactic body radiation therapy (SBRT), or a combination of chemotherapy and radiation; advanced stages may involve systemic therapies such as chemotherapy, targeted agents, or immunotherapy, often combined with radiation therapy such as intensity-modulated radiation therapy (IMRT). Small cell lung cancer is generally managed with chemotherapy and radiation, and all decisions about sequencing and combining treatments are made by a multidisciplinary team following individual assessment.
Can Lung Cancer be treated without a procedure?
Non-surgical pathways are well established and clinically significant for lung cancer. Stereotactic body radiation therapy (SBRT) is a recognised standard for early-stage tumours in patients who are not surgical candidates or who prefer to avoid surgery. For locally advanced or metastatic disease, chemotherapy, immunotherapy, targeted molecular therapies, and radiation therapy (including IMRT) form the backbone of treatment — meaning many patients receive effective care without any surgical procedure.
When is Immunotherapy considered for Lung Cancer?
Immunotherapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Lung Cancer?
Lung cancer is typically evaluated and managed by a multidisciplinary team that may include a thoracic oncologist or medical oncologist (who oversees systemic therapies), a radiation oncologist (who plans and delivers SBRT or IMRT), a thoracic surgeon (for surgical cases), and a pulmonologist involved in initial diagnosis. A dedicated lung cancer tumour board — where specialists review each case collectively — is considered best practice at experienced centres.
How do I choose a doctor for Lung Cancer?
When comparing providers, look for centres with a dedicated thoracic or lung cancer programme, access to molecular tumour profiling, and an active multidisciplinary tumour board, as these factors are associated with more personalised and coordinated care. It is also worth asking about the radiation oncology team's specific experience with SBRT and IMRT for lung tumours, the technology available (such as image-guided or motion-management systems), and what structured follow-up and supportive care are offered after treatment.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.